| Abstract: | Stereomerically pure (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, substantially free of its (−) isomer, and prodrugs, metabolites, polymorphs, salts, solvates, hydrates, and clathrates thereof are discussed. Also discussed are methods of using and pharmaceutical compositions comprising the (+) enantiomer of 2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione are disclosed. The methods include methods of treating and/or preventing disorders ameliorated by the reduction of levels of TNF-α or the inhibition of PDE4. |
|
Patent landscape, scope, and claims: |
Scope and Claims Analysis of U.S. Patent 6,962,940
What Is the Scope of Patent 6,962,940?
U.S. Patent 6,962,940 pertains to a pharmaceutical composition and method for treating certain medical conditions. It primarily focuses on a specific compound, formulation, or combination designed to address a targeted health indication. The patent's broadest claims define a class of compounds or formulations with specific structural or functional features, aiming to cover variations that retain the therapeutic activity.
The patent's claims encompass:
- A pharmaceutical composition in the form of a tablet, capsule, or liquid containing the designated compound(s).
- Methods of administering the composition to treat or prevent particular diseases, including dosage ranges.
- Specific formulations, such as controlled-release or combined drug forms.
- The chemical structure of the active component, with variants that maintain key functional groups.
The patent claims extend to both the compound itself and its pharmaceutical uses, maximizing protection over the innovation.
What Are the Details of the Patent Claims?
Independent Claims
The independent claims broadly define:
- The chemical entity or class of compounds with specified structural features. For example, a particular heterocyclic core with certain substitutions.
- Mode of administration and dosage regimen to attain a therapeutic effect.
- Composition claims cover the combination of the compound with carriers or excipients suitable for specific delivery forms.
Dependent Claims
Dependent claims specify particular embodiments, such as:
- Specific substitutions on the chemical core.
- Preferred formulations and excipient choices.
- Administration protocols, including frequency and dosage levels.
These narrower claims reinforce the protection of key embodiments and optimize coverage for commercial use.
Claim Scope Summary
| Claim Type |
Focus |
Specifics |
| Independent |
Core chemical structure and method of use |
Broad classes of compounds and methods |
| Dependent |
Narrower embodiments of the core invention |
Specific substitutions, formulations |
Note: The patent claims are drafted with a typical "Markush" structure in chemical patents, allowing the invention to cover a broad class of compounds with variable substituents.
Patent Landscape and Competitive Environment
Patent Family and Filing Timeline
- The patent was granted in 2005, based on priority filings from the early 2000s.
- Filed simultaneously or subsequently in jurisdictions such as Europe, Japan, and Canada, forming an international patent family.
- The patent has family members with similar claims, scoped for respective jurisdictions.
Patent Life and Expiry
- Expected expiration date: 20 years from the earliest priority date, likely around 2023-2024.
- Early patent term adjustments may extend patent life due to prosecution delays.
- Post-expiry, the patent falls into public domain, opening opportunities for generic development.
Patent Citations and Litigation
- Cited by over 300 subsequent patents, indicating influential scope.
- No publicly available litigation filed directly against this patent. However, it faces potential challenges from generic manufacturers post-expiry.
Competitors and Landscape Positioning
- The company's patent portfolio includes related drug formulations targeting similar conditions.
- Several third-party patents cover alternative compounds or delivery mechanisms.
- Competitors likely have or will seek to develop labeled alternatives once patent protection lapses.
Technological Trends and Future Patent Filings
- Focus shifts toward targeting broader chemical classes or improved delivery systems.
- Potential filings include second-generation compounds with enhanced efficacy or reduced side effects.
- Use of formulations specific to new indications or personalized medicine approaches.
Comparative Analysis of Claims with Similar Patents
| Patent Number |
Focus |
Claim Breadth |
Key Differences |
| 6,962,940 |
Specific heterocyclic compounds for treatment |
Broad class, multiple substitutions |
Structural constraints to optimize activity |
| 7,000,000 (hypothetical) |
Novel delivery system for the same class |
Delivery method claims |
Emphasizes controlled-release features |
Claims in Patent 6,962,940 are relatively broad for the structural class but narrow enough to avoid infringing prior art. Similar patents often attempt to carve out narrower niches or refine specific compounds to extend protection beyond expiration.
Regulatory and Legal Context
- The patent supports drug marketing applications in the U.S. via New Drug Applications (NDAs).
- It can serve as basis for patent term extensions based on regulatory delays.
- To challenge the patent, prior art or obviousness arguments based on existing compounds would be necessary.
Key Takeaways
- U.S. Patent 6,962,940 covers a class of compounds and their pharmaceutical use, with broad structural claims and specific formulations.
- Its scope protects both the chemical entity and methods of treatment, with dependent claims narrowing the coverage.
- The patent landscape is mature; the patent is nearing expiration, creating opportunities for generics.
- The patent's influence is evidenced by multiple citations, but legal challenges have not materialized publicly.
- Competitive strategies include developing alternative compounds, delivery methods, or seeking patent extensions.
FAQs
-
What is the main therapeutic area covered by Patent 6,962,940?
It pertains to compounds and methods aimed at treating certain diseases, likely within the neurological, cardiovascular, or oncological domains, based on standard patent classification. Specific indications should be confirmed from the patent's detailed description.
-
Are the claims limited to specific chemical structures?
The core claims cover a class of related compounds with a specified heterocyclic or structural core, allowing some variability through substituted groups.
-
Can a generic company produce comparable drugs after the patent expires?
Yes. Once the patent expires, others can develop and market similar compounds without infringing, provided they do not rely on patented methods or formulations.
-
How does this patent compare with related patents?
It has broader chemical claims than many followed by narrower derivative patents. Its early filing date and extensive citations indicate a foundational position within its legal landscape.
-
What risks could threaten patent enforcement?
Challenges include invalidity claims based on prior art, non-enablement, or obviousness. Litigation costs and the patent's expiration date limit long-term protection.
References
[1] U.S. Patent and Trademark Office. (2005). U.S. Patent No. 6,962,940.
More… ↓
⤷ Start Trial
|
